IBJNews

Marcadia Biotech principals ponder next course

Back to TopCommentsE-mailPrintBookmark and Share

As if it wasn’t enough of an achievement to sell a 5-year-old startup for what may total $537 million when all the money is counted.

The 11-employee Marcadia Biotech Inc. was generating enough cash flow prior to its sale to Swiss lifes sciences giant Roche that its investors ran into an unusual problem.

“Our venture-capital firms were going crazy. They never had a company that had to pay taxes,” said Fritz French, former CEO of Carmel-based Marcadia.

French and Kent Hawryluk, vice president of business development, on Tuesday morning outlined the company’s brief but lucrative life.

BioCrossroads' “Frameworx” discussion series drew more than 50 life science leaders to the 48th floor of Chase Tower. The setting was appropriate, given Carmel-based Marcadia’s lofty accomplishments. It’s become an affirmation of sorts that a company far removed from the venture-capitalist-clustered East and West Coasts can rise and flourish in central Indiana.

“It’s the kind of story that makes you say, ‘If these guys can do it, maybe I can, too,’” said David Johnson, CEO of BioCrossroads.

December's sale to Switzerland-based Roche is expected to generate at least $287 million for the company’s owners initially. Investors could reap an additional $250 million if one of Marcadia’s experimental drugs to treat diabetes reaches market.

Hawryluk noted the benefits of Marcadia’s earlier partnership with Merck, which helped finance the firm’s growth, in addition to the more than $15 million in venture capital that was raised.

Although neither he nor French would elaborate on the value of that partnership, “we still had $37 million on the books when we sold the company,” French said.

Marcadia was founded by Hawryluk and former Eli Lilly and Co. scientists Richard DiMarchi and Gus Watanabe.

The participation of the former Lilly scientists provided “instant credibility,” French said, an advantage that many startups don’t enjoy.

Marcadia also successfully deployed what has become standard practice of major pharmaceutical companies in recent years—operating on largely a contract basis with outside firms. Much of the work was conducted in DiMarchi’s laboratory at Indiana University, with compounds it generated outsourced to other partners, including a research center at the University of Cincinnati.

French and Hawryluk told of a razor-edge walk to engage interest in partners—first those with which they’d enter licensing agreements and later to seek a buyer.

“We really felt that we were getting terms we might not see again for at least a year or two,” Hawryluck said of the process as momentum for a sale grew last summer.

Playing into Marcadia’s favor was a handful of failures Roche had of late in snapping up small players in the diabetes sector.

“Wall Street had expected them to be in this area,” French said.

Marcadia is being absorbed within Roche. French and Hawryluk have been talking to Roche execs about possibly licensing a short-acting glucagon that Marcadia has been developing that could be used to treat those suffering episodes of low blood sugar. A deal could spawn a new company for the duo, but French was unsure Tuesday whether an agreement could be reached.

If that doesn’t transpire, “I don’t know (what I’ll do),” he said, responding to an audience question. “I’ll probably take a few months and think about what I’ll do next.”
 

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. I am a Lyft driver who is a licensed CDL professional driver. ALL Lyft drivers take pride in providing quality service to the Indianapolis and surrounding areas, and we take the safety of our passengers and the public seriously.(passengers are required to put seat belts on when they get in our cars) We do go through background checks, driving records are checked as are the personal cars we drive, (these are OUR private cars we use) Unlike taxi cabs and their drivers Lyft (and yes Uber) provide passengers with a clean car inside and out, a friendly and courteous driver, and who is dressed appropriately and is groomed appropriately. I go so far as to offer mints, candy and/or small bottle of water to the my customers. It's a mutual respect between driver and passenger. With Best Regards

  2. to be the big fish in the little pond of IRL midwest racin' when yer up against Racin' Gardner

  3. In the first sentance "As a resident of one of these new Carmel Apartments the issue the local governments need to discuss are build quality & price." need a way to edit

  4. As a resident of one of these new Carmel Apartments the issue the local governments need to discuss is build quality & price. First none of these places is worth $1100 for a one bedroom. Downtown Carmel or Keystone at the Crossing in Indy. It doesn't matter. All require you to get in your car to get just about anywhere you need to go. I'm in one of the Carmel apartments now where after just 2.5 short years one of the kitchen cabinet doors is crooked and lawn and property maintenance seems to be lacking my old Indianapolis apartment which cost $300 less. This is one of the new star apartments. As they keep building throughout the area "deals" will start popping up creating shoppers. If your property is falling apart after year 3 what will it look like after year 5 or 10??? Why would one stay here if they could move to a new Broad Ripple in 2 to 3 years or another part of the Far Northside?? The complexes aren't going to let the "poor" move in without local permission so that's not that problem, but it the occupancy rate drops suddenly because the "Young" people moved back to Indy then look out.

  5. Why are you so concerned about Ace hardware? I don't understand why anyone goes there! Every time ive gone in the past, they don't have what I need and I end up going to the big box stores. I understand the service aspect and that they try to be helpful but if they are going to survive I think they might need to carry more specialty parts.

ADVERTISEMENT